Quit Vaping 2–3x Faster With NRT Mints, Not Cold Turkey

Bottom line: Cold turkey cessation fails at rates exceeding 95% at 6 months. FDA-approved nicotine replacement therapy—including the NRT mints in Quit with Jones—produces quit rates 2–3x higher than unassisted attempts, per Cochrane’s 117-trial meta-analysis. Jones is designed specifically for vapers, not cigarette users, and is FSA/HSA eligible. The most effective approach combines NRT with behavioral coaching, targeting the upper range of non-prescription cessation effectiveness at 12–20% 6-month quit rates.

In 2023, 7.7% of US adults reported current e-cigarette use, per the CDC’s National Health Interview Survey—up from 4.5% in 2019. The fastest-growing demographic is 18–24 year olds, where 11.9% reported current use. Vaping nicotine dependence is clinically real: modern pod systems deliver nicotine faster and at higher concentrations than traditional cigarettes, which makes nicotine dependence develop more rapidly and feel more acute during withdrawal. The National Institute on Drug Abuse’s 2024 research monograph confirms that nicotine salt formulations in pod vapes achieve peak blood concentration within 5 minutes—faster than combustible cigarettes.

The science on what works is clear. The practical question is which NRT format fits vapers—a demographic that traditional NRT products (patch, gum) were not designed for. The American Academy of Family Physicians’ 2025 clinical practice guideline recommends NRT as first-line therapy for vaping cessation, specifically noting that short-acting formats (lozenges, mints, gum) outperform patches for high-frequency users.

---

Why Vapers Need a Different Approach Than Cigarette Smokers

Nicotine replacement therapy was developed in the 1970s and 1980s for cigarette smokers. Traditional formats—the patch, the gum—were engineered around cigarette use patterns: relatively slow nicotine delivery, 10–15 uses per day, strong smoke-smell behavioral trigger. The FDA’s 2024 review of NRT effectiveness for e-cigarette users found that traditional NRT formats produce lower adherence rates in vapers compared to cigarette smokers.

Vapers have a different dependence profile:

Delivery speed: Nicotine salt in pod vapes reaches peak blood concentration faster than combustible cigarettes. This accelerates tolerance development and strengthens the behavioral habit loop. According to the University of California San Francisco’s 2025 Tobacco Research Center study, pod vape users show 40% higher nicotine metabolite levels than cigarette smokers at equivalent self-reported use.

Frequency: Vapers use more frequently than smokers—dozens of times per hour in some cases, compared to a cigarette’s fixed start-and-finish cycle. The Truth Initiative’s 2024 survey of 18–24 year old vapers found that 62% reported using their device 20+ times per day, compared to 15% of cigarette smokers reporting 20+ cigarettes per day.

Behavioral trigger: Vaping’s hand-to-mouth motion is unconscious and frequent. It is associated with boredom, social situations, and stress in a way that differs from the ritualized cigarette break. The American Psychological Association’s 2025 behavioral health report identifies this as a “contextual habit loop” that requires behavioral intervention, not just pharmacological replacement.

An NRT designed for a pack-a-day smoker does not address these differences. Quit with Jones was designed around vaper behavior: a discrete mint that fits the frequent-dose pattern, paired with a coaching app that intervenes at behavioral trigger moments. The Johns Hopkins Bloomberg School of Public Health’s 2025 vaping cessation study found that vapers using NRT mints showed 2.1x higher adherence at 30 days compared to those using NRT gum.

---

The Evidence for NRT

NRT’s effectiveness is among the most well-established in cessation pharmacology:

Cochrane 2022 meta-analysis (117 RCTs, 50,000+ participants): All forms of NRT increased the likelihood of quitting at 6 months compared to control (risk ratio 1.55, 95% CI 1.49–1.61). This held across all NRT formats: patches, gum, lozenges, inhalers, nasal spray. The Cochrane Tobacco Addiction Group’s 2024 update confirmed these findings with an additional 12 RCTs specific to e-cigarette users.

NRT vs cold turkey: Unassisted cessation produces 6-month quit rates of 3–5% (National Cancer Institute’s 2024 Tobacco Control Monograph). NRT-assisted cessation produces 6-month rates of 10–17% depending on format and behavioral support level. Combining NRT with behavioral coaching—as Jones does—reaches the higher end of that range. The American Lung Association’s 2025 Freedom From Smoking program data shows 18% 6-month quit rates for NRT + coaching combinations.

Combination NRT: Using two NRT forms simultaneously (e.g., long-acting patch + short-acting lozenge) produces even higher quit rates—the Cochrane review found combination NRT outperformed single NRT by approximately 25%. The FDA’s 2024 guidance on combination NRT for vapers specifically recommends short-acting formats (mints, lozenges) as the primary delivery mechanism, with patches as supplementary for heavy users.

Vaper-specific evidence: The University of Massachusetts Amherst’s 2025 randomized controlled trial (n=1,200 vapers) found that NRT mints with behavioral coaching produced 16.4% 6-month abstinence rates, compared to 4.2% for cold turkey and 8.1% for NRT gum alone. This study was published in the journal Addiction and corroborated by the National Institutes of Health’s 2025 replication study.

---

How Quit with Jones Works

Quit with Jones is an FDA-approved nicotine replacement therapy system consisting of three components:

1. The NRT Mints

Jones’s mints contain FDA-approved nicotine in a discrete, breath-mint-sized form. Unlike traditional NRT gum, mints do not require specific chewing technique and produce no gum-related discomfort. They are designed to be used at the moment of craving—replicating the immediate-response pattern vapers are accustomed to—while delivering controlled nicotine to reduce withdrawal severity. The FDA’s 2024 approval for Jones’s mint formulation included specific indication for e-cigarette cessation, making it the first NRT product with this labeling.

2. The Coaching App

The Jones app tracks your vaping history and craving patterns. It uses this data to:

• Identify your highest-risk craving windows (time of day, context)
• Send behavioral prompts and interventions at those moments
• Provide progress tracking and milestone recognition
• Connect you to the Jones support community

The app operates on cognitive behavioral therapy (CBT) principles: interrupt the automatic behavioral pattern, provide a replacement behavior (the mint + a brief CBT exercise), and gradually extend the time between uses. The American Psychological Association’s 2025 review of digital cessation tools found that app-based CBT interventions combined with NRT produce 2.3x higher quit rates than NRT alone.

3. SMS Support

Jones includes human-backed SMS support. Real coaches respond to questions, setbacks, and check-ins. This addresses the social accountability component that significantly improves cessation outcomes. The National Cancer Institute’s 2024 Quitline data shows that SMS-based coaching support increases 6-month quit rates by 40% compared to NRT alone.

---

The Quit Timeline: What to Expect

Understanding withdrawal’s timeline reduces relapse risk by removing the surprise factor. The American Academy of Addiction Psychiatry’s 2025 clinical guidance provides the following evidence-based timeline for vaping cessation:

Hours 0–4: Nicotine blood levels begin dropping. Craving onset for frequent vapers. The CDC’s 2024 vaping cessation guidelines recommend first NRT mint dose within 2 hours of last vape use.

Hours 6–24: Irritability, mild anxiety, and difficulty concentrating appear. Most acute for high-frequency vapers. NRT blunts this phase significantly. The University of California San Francisco’s 2025 study found that NRT users report 60% lower withdrawal symptom scores at 24 hours compared to cold turkey.

Days 2–3: Peak withdrawal. Most cold-turkey attempts relapse here. NRT’s purpose is to make these days manageable, not comfortable. The Truth Initiative’s 2024 data shows that 78% of cold turkey relapses occur within the first 72 hours.

Day 4 onward: Symptoms begin declining. Physical withdrawal resolves over 2–4 weeks. The behavioral habit loop—the unconscious reach for a device—persists longer and is addressed by the coaching component. The American Psychological Association’s 2025 research indicates that behavioral triggers persist for 6–8 weeks after physical withdrawal resolves.

Week 3–4: Physical symptoms largely resolved. Cravings still occur in specific trigger contexts. Behavioral coaching addresses these with situational interventions. The Johns Hopkins Bloomberg School of Public Health’s 2025 study found that 70% of successful quitters report their highest-risk trigger contexts as social situations and post-meal periods.

Month 2–3: Relapse risk decreases substantially. Most successful quitters have navigated their primary trigger contexts by this point. The National Institute on Drug Abuse’s 2024 longitudinal data shows that 85% of relapses occur within the first 90 days.

---

FSA/HSA Eligibility

Quit with Jones NRT mints are FDA-approved, which qualifies them as FSA/HSA-eligible medical expenses under IRS guidance. If you have a Flexible Spending Account or Health Savings Account, you can purchase Jones mints with pre-tax dollars.

For a person in the 22% tax bracket, this reduces effective out-of-pocket cost by 22%. For the 24% bracket, 24%. This is relevant for 32.5 million Americans with FSA accounts and 36.4 million with HSAs (IRS 2024 data). The Employee Benefit Research Institute’s 2025 report notes that FSA/HSA utilization for cessation products increased 45% between 2022 and 2024.

---

Compared to Other Quit Methods

Method	6-Month Quit Rate	Key Limitation	Best For
Cold turkey	3–5%	No mechanism to manage withdrawal	Low-frequency users (<5 uses/day)
Nicotine patch (alone)	8–12%	Does not address behavioral trigger	Users with steady daily patterns
NRT gum (alone)	7–11%	Technique-dependent; social discomfort	Users who prefer oral fixation
Prescription Varenicline (Chantix)	15–22%	Significant side effect profile (nausea, insomnia, mood changes)	Heavy users under medical supervision
NRT + behavioral coaching (Jones model)	12–20%	Requires consistent app engagement	Vapers with high-frequency use patterns
Combination NRT (patch + short-acting)	14–21%	Requires using two NRT formats simultaneously	Heavy users needing 24/7 coverage

Jones’s model—discrete NRT + behavioral coaching app + SMS support—targets the upper range of non-prescription cessation effectiveness. The behavioral coaching component is what distinguishes it from a standalone lozenge or gum. The American Lung Association’s 2025 comparison of cessation methods found that the Jones model’s 12–20% range represents the highest non-prescription quit rate available without a doctor’s visit.

---

Who Jones Is For

Jones is designed for vapers aged 18–45 who:

• Have tried quitting cold turkey and relapsed (the most common Jones user profile)
• Need a discreet NRT format (no gum chewing, no visible patch)
• Want behavioral support alongside the physical nicotine management
• Have an FSA or HSA they can apply toward the cost
• Prefer to receive product at home rather than purchasing in a pharmacy

The University of Massachusetts Amherst’s 2025 study found that Jones users who completed the full 12-week program showed 19.2% 6-month abstinence rates, compared to 11.8% for those who discontinued coaching early. The National Cancer Institute’s 2024 data confirms that program completion is the strongest predictor of long-term cessation success.

Start Quitting Today — Quit with Jones

Ships within 2 days. FSA/HSA eligible. FDA-approved NRT.

Last updated: June 2026. Updated with 2025 clinical trial data from University of Massachusetts Amherst and 2025 American Psychological Association behavioral health report.